Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
hsa-mir-1197: Hsa-mir-1197 is a microRNA that has been studied in various contexts [PMC5710922]. It has been found to have a similar expression profile to RNA-seq findings [PMC5710922] and its expression has been validated in blood samples of patients and healthy controls [PMC5710922]. Differential expression of hsa-mir-1197 has been observed in patients compared to healthy controls [PMC5710922]. Hsa-mir-1197 is one of the hub miRNAs in a ceRNA network and its expression level is lower in patients with lung cancer compared to normal controls [PMC5710922]. It has also been identified as one of the miRNAs downstream of hsa_circ_0006091 [PMC8973770]. Bioinformatics analysis suggests that hsa-mir-1197 may be involved in post-transcriptional regulation and can bind to the 3'-UTR of RIPK1 [PMC7191703]. The rs17548629 C>T variant can affect the binding strength between hsa-mir-1197 and RIPK1 [PMC7191703]. Hsa-mir-1197 has also been found to be associated with inhibiting virus replication, such as SARS-CoV-2 replication [PMC8890551]. It is targeted by other miRNAs, such as hsa-miR-520h, hsa-miR-1298, and hsa-miR 520g [PMC8483823]. Hsa-mir-1197 has also been associated with cancer progression, including bladder cancer, lung cancer, and prostate cancer [PMC8414803]. Overall, hsa-mir-1197 plays a role in various biological processes and its dysregulation may have implications for disease development [PMC8414803].
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset